Comparison of Clinical Findings and Nutritional Status in Women with Poly Cystic Ovarian Syndrome in 18-29 and 30-45 Year Age Groups

Jump To References Section

Authors

  • Department of Food Science and Nutrition, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore - 641 043 ,IN
  • Department of Food Science and Nutrition, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore - 641 043 ,IN

DOI:

https://doi.org/10.21048/IJND.2021.58.3.28401

Keywords:

Polycystic ovarian syndrome, mean nutrient intake, dietary intake, nutritional status, micronutrients, vitamin D

Abstract

Poly cystic ovarian syndrome (PCOS) is a heterogeneous disorder common among reproductive age women. The study was focused to compare the clinical findings and nutritional status of women with PCOS in 18-29 and 30-45 year age groups. Overall, 120 PCOS subjects in the age group of 18-45 years were selected for the study. Rotterdam criteria was used for identification of the subjects for the study. Socio economic status of the subject revealed that majority of the subjects (49 %) belonged to upper lower class IV. There was a significant mean difference in BMI (p=0.007), Oligo an ovulation (p=0.02) between the two groups. The mean Scores of hirsutism and physical activity was significantly higher in the 18-29 age group (p<0.05). Nutrient intake was assessed by three day food record and food frequency questionnaire (FFQ) and calculated using Diet Cal software. The mean intake of calorie, carbohydrate and fat was remarkably higher in both age groups whereas the intake of micronutrients such as calcium, zinc, iron and retinol was lower compared to EAR. Vitamin D intake was lower than the EAR in all the selected subjects. The comparison of nutritional status of the two age groups disclosed that there was a significantly higher mean intake of calorie (p=0.045), fibre (p=0.006), iron (p=0.022), magnesium (p=0.017), chromium (p=0.016) and potassium (p=0.041) in the 30-45 year age group. Food consumption pattern affirmed that there was a remarkable difference in the intake of processed foods, soft drinks, sweets, fish, leafy vegetables, pickle between the two age groups.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Published

2021-09-07

How to Cite

Krishnan, J. S., & Devi A., T. (2021). Comparison of Clinical Findings and Nutritional Status in Women with Poly Cystic Ovarian Syndrome in 18-29 and 30-45 Year Age Groups. The Indian Journal of Nutrition and Dietetics, 58(3), 350–360. https://doi.org/10.21048/IJND.2021.58.3.28401

Issue

Section

Original Articles

 

References

Moran, L. J., Ranasinha, S., Zoungas, S., McNaughton, S.A., Brown, W.J. and Teede H.J. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod., 2013, 28, 2276-2283. DOI: https://doi.org/10.1093/humrep/det256

Asemi, Z. and Esmaillzadeh, A. DASH diet, insulin resistance and serum hs-CRP in polycystic ovary syndrome: A randomized controlled clinical trial. Hormone set metabolisme, 2015, 47, 232-238. DOI: https://doi.org/10.1055/s-0034-1376990

Douglas, C.C., Norris, L.E., Oster, R.A., Darnell, B.E., Azziz, R. and Gower, B.A. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertill Sterill., 2006, 86, 411-417. DOI: https://doi.org/10.1016/j.fertnstert.2005.12.054

Ruder, E.H., Hartman, T.J. and Goldman, M.B. Impact of oxidative stress on female fertility. Curr. Opin. Obsted. Gynecol., 2009, 21, 219-2 DOI: https://doi.org/10.1097/GCO.0b013e32832924ba

Pal, L., Berry, A., Coraluzzi, L., Kustan, E., Danton, C., Shaw, J., et al. Therapeutic implications of vitamin D and calcium in overweight women with Polycystic Ovary Syndrome. Gynecol. Endocrinol., 2018, 28, 965-968. DOI: https://doi.org/10.3109/09513590.2012.696753

Oner G. Muderris. Efficacy of omega-3 in the treatment of polycystic ovary syndrome. J. Obstet. Gynaecol., 2013, 33, 289-229. DOI: https://doi.org/10.3109/01443615.2012.751365

Jamilian, M., Shirin Mansury, Fereshteh Bahmani, Zahra Heidar, Elaheh Amirani and Zatollah. Supplementation on parameters of mental health, hormonal profiles and biomarkers of inflammation and oxidative stress in women with poly cystic ovary syndrome. J. Ovarian Res., 2018, 11, 80. DOI: https://doi.org/10.1186/s13048-018-0457-1

Saleem, S.M. Modified Kuppuswamy socio-economic scale updated for the year 2020. Ind. J. Forensic Community. Med., 2020, 7. DOI: https://doi.org/10.18231/j.ijfcm.2020.001

Ferriman, D. and Purdie, A.W. The aetiology of oligomenorrhoea and/or hirsuties: A study of 467 patients. Postgrad. Med. J., 1983, 59,17-20. DOI: https://doi.org/10.1136/pgmj.59.687.17

Roshaslinie Ramli, Aamir Saeed Malik, Ahmad Fadzil Mohamad Hani and Adawiyah Jamil. Acne analysis, grading and computational assessment methods: An overview. Res. Technol., 2012, 18, 1-14 DOI: https://doi.org/10.1111/j.1600-0846.2011.00542.x

Cohen, S. and Williamson, G. Perceived Stress in a Probability Sample of theUnited States. Spacapan, S. and Oskamp, S. (Eds.). The Social Psychology of Health. Newbury Park, CA: Sage, 1988.

Godin,G.The Godin-Shephard leisure-time physical activity questionnaire. Heal. Fitness J. Canada., 2011, 4, 18-22

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W. Positions statement: Criteria for defining poly cystic ovary syndrome as a predominantly hyper androgenic syndrome: An Androgen Excess Society guideline. J. Clin. Endocrinol. Metab., 2006, 91, 4237-4245. DOI: https://doi.org/10.1210/jc.2006-0178

Twigt, J.M., Hammiche, F. and Sinclair, K.D. Pre conceptional folic acid use modulates estradiol and follicular responses to ovaria stimulation. J. Clin. Endocrinol. Metab., 2011, 96, 322-329.

Narges Zaeemzadeh, Shahideh Jahanian Sadatmahalleh, Saeideh Ziaei Anoshirvan Kazemnejad, Maryam Movahedinejad, Azadeh Mottaghi and Neda Mohamadzadeh. Comparison of dietary micronutrient intake in pcos patients with and without metabolic syndrome. J. Ovarian Res., 2021, 14, 5-9. DOI: https://doi.org/10.1186/s13048-020-00746-0

Azelian, S., Rouhani, M.H., Bank, S.S. and Amani, R. Chromium supplementation and poly cystic ovary syndrome: A systematic review and meta-analysis. J. Trace Elem. Med., Biol.,2016, 42, 92-96. DOI: https://doi.org/10.1016/j.jtemb.2017.04.008

Tang, X.L., Sun, Z. and Gong, L. Chromium supplementation in women with poly cystic ovary syndrome: Systematic review and meta-analysis. J. Obstet. Gynaecol. Res., 2018, 44,134-143. DOI: https://doi.org/10.1111/jog.13462

Jamilian, M., ZaehModarres, S., AmiriSiavashani, M., Karimi, M., Mafi, A., Ostadmohammadi, V., et al.The influences of chromium supplementation on glycemic control, markers of cardio metabolic risk and oxidative stress in infertile poly cystic ovary syndrome women candidate for in vitro fertilization: A randomized, double-blind. Placebo-Controlled Trial Biol. Trace Element Res., 2018 ,185, 48–55. DOI: https://doi.org/10.1007/s12011-017-1236-3

Abedini, M., Ghaedi, E., Hadi, A., Mohammadi, H., Amani, R. Zinc status and poly cystic ovarian syndrome: A systematic review and meta-analysis. J. Trace Elem. Med., Biol., 2019, 52, 216–221. DOI: https://doi.org/10.1016/j.jtemb.2019.01.002

Conclaves, A., Amiot, M.J. Fat-soluble micronutrients and metabolic syndrome. Curr. Opin. Clin. Nutr. Metab. Care., 2017, 20, 492–497. DOI: https://doi.org/10.1097/MCO.0000000000000412